85 results
Page 2 of 5
8-K
EX-99.1
q5yg7n194fck s02a
9 May 22
Adaptimmune Reports First Quarter Financial Results and Business Update
7:40am
8-K
wzu39l
12 Nov 21
Adaptimmune Reports Positive Results from its Pivotal SPEARHEAD-1 Trial in Patients with Synovial Sarcoma and MRCLS at CTOS
6:30am
8-K
EX-99.1
1lkrjezt8
12 Nov 21
Adaptimmune Reports Positive Results from its Pivotal SPEARHEAD-1 Trial in Patients with Synovial Sarcoma and MRCLS at CTOS
6:30am
8-K
EX-99.1
2hsb9htr1
4 Nov 21
Adaptimmune Reports Third Quarter Financial Results and Business Update
7:40am
8-K
EX-99.1
8e1rp061y7b1vy04wd1
13 Sep 21
Other Events
7:08am
8-K
i2y52pd4giv1fbft9dzv
13 Sep 21
Other Events
7:08am
8-K
EX-99.1
mp19zwyxkb1l wda
9 Aug 21
Adaptimmune Reports Second Quarter Financial Results and Business Update
4:08pm
8-K
88e5puj9b25r
19 May 21
Two Complete Responses and Response Rate of 41% for People with Synovial Sarcoma Reported at ASCO in Adaptimmune’s Phase 2 SPEARHEAD-1 Trial
5:08pm
8-K
EX-99.1
u6yz0vwdo oh55q2mun
19 May 21
Two Complete Responses and Response Rate of 41% for People with Synovial Sarcoma Reported at ASCO in Adaptimmune’s Phase 2 SPEARHEAD-1 Trial
5:08pm
8-K
EX-99.1
dzf3xj rqk49v87
6 May 21
Adaptimmune Reports First Quarter Financial Results and Business Update
7:38am
8-K
EX-99.1
dd2ij nno40mtf4v
25 Feb 21
Adaptimmune Reports Fourth Quarter / Full Year 2020 Financial Results and Business Update
7:37am